Donate to I-ELCAP

Management System

I-ELCAP Publications

  1. Henschke CI, Miettinen OS, Yankelevitz DF, Libby D, Smith JP. Radiographic screening for cancer. Proposed paradigm for requisite research. Clin Imaging 1994; 18:16-20.
  2. Miettinen OS, Henschke CI, Yankelevitz DF. Evaluation of diagnostic imaging tests: diagnostic probability estimation. J Clin Epidemiol 1998; 51:1293-8.
  1. Yankelevitz DF, Shaham D, Shah A, Rademacker J, Henschke CI. Optimization of contrast delivery for pulmonary CT angiography. Clin Imaging 1998; 22:398-403.
  1. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, Libby DM, Pasmantier MW, Koizumi J, Altorki NK, Smith JP. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999; 354:99-105.
  1. Yankelevitz DF, Gupta R, Zhao B, Henschke CI. Small Pulmonary Nodules: evaluation with repeat CT-preliminary experience. Radiology 1999; 212:561-6.
  1. Zhao B, Yankelevitz D, Reeves A, Henschke C. Two-dimensional multi-criterion segmentation of pulmonary nodules of helical CT images. Med Phys 1999; 26:889-95.
  1. Zhao B Reeves A, Yankelevitz DF, Henschke CI. Three-dimensional multi-criterion automatic segmentation of pulmonary nodules of helical CT images. Optical Engineering 1999; 38:1340-7.
  1. Shah AA, Buckshee N, Yankelevitz DF, Henschke CI. Assessment of deep venous thrombosis using pelvic CT. AJR Am J Roentgenol 1999; 173:659-63.
  1. Reeves AP, Kostis WJ, Yankelevitz DF, Henschke CI. Three-dimensional shape characterization of solitary pulmonary nodules from helical CT scans. Proceedings of Computer Assisted Radiology in Surgery (CARS ‘99). (Eds: HU Lempke, MW Vannier, K Inamura, AG Farman.) Elsevier Science 1999:83-7.
  1. Kostis WJ, Reeves AP, Yankelevitz DF, Henschke CI. Three-dimensional segmentation of solitary pulmonary nodules from helical CT scans. Proceedings of Computer Assisted Radiology in Surgery (CARS ‘99). (Eds: HU Lempke, MW Vannier, K Inamura, AG Farman). Elsevier Science 1999:203-7.
  1. Zhao B, Kostis WJ, Reeves AP, Yankelevitz DF, Henschke CI. Consistent segmentation of repeat CT scans for growth assessment in pulmonary nodules. Proceedings of the SPIE, Medical Imaging 1999; 3661:1012-18.
  1. Yankelevitz DF, Vazquez M, Henschke CI. Special techniques in transthoracic needle biopsy of pulmonary nodules. Radio Clin of North Am 2000; 38:267-79.
  1. Yankelevitz DF, Henschke CI. Small solitary pulmonary nodules. Radio Clin of North Am 2000; 38:471-8.
  1. Henschke CI, Yankelevitz DF. CT screening for lung cancer. Radio Clin of North Am 2000; 38:487-95.
  2. Cham MD, Yankelevitz DF, Shaham D, Shah AA, Sherman L, Lewis A, Rademaker J, Pearson G, Choi J, Wolff W, Prabhu PM, Galanski M, Clark R, Sostman HD, Henschke CI. Deep venous thrombosis: detection by using indirect CT venography. The Pulmonary Angiography-Indirect CT Venography Cooperative Group. Radiology 2000; 216:744-51.
  3. Mulshine JL. Henschke CI. Prospects for lung-cancer screening. Lancet 2000; 355:592-3.
  4. Henschke CI. Early Lung Cancer Action Project: Overall Design and Findings from Baseline Screening. Cancer 2000; 89:2472-82.
  1. Henschke CI, Yankelevitz D, Westcott J, Davis SD, Fleishon H, Gefter WB, McLoud TC, Pugatch RD, Sostman HD, Tocino I, White CS, Bode FR, Swensen SJ. Work-up of the solitary pulmonary nodule. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000; 215:607-9.
  1. McLoud TC, Westcott J, Davis SD, Fleishon H, Gefter WB, Henschke CI, Pugatch RD, Sostman HD, Tocino I, White CS, Yankelevitz D, Bode FR. Staging of bronchogenic carcinoma, non-small cell lung carcinoma. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000; 215:611-9.
  1. Tocino I, Westcott J, Davis SD, Fleishon H, Gefter WB, Henschke CI, McLoud TC, Pugatch RD, Sostman HD, White CS, Yankelevitz D, Bode FR, Goodman LR. Routine daily portable x-ray. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000; 215:621-6.
  1. Westcott J, Davis SD, Fleishon H, Gefter WB, Henschke CI, McLoud TC, Pugatch RD, Sostman HD, Tocino I, White CS, Yankelevitz D, Bode FR, Critchfield C. Routine chest radiographs in uncomplicated hypertension. American College of Radiology. ACR. Appropriateness Criteria. Radiology 2000; 215:627-9.
  1. Fleishon H, Westcott J, Davis SD, Gefter WB, Henschke CI, McLoud TC, Pugatch RD, Sostman HD, Tocino I, White CS, Yankelevitz D, Bode FR, Goodman LR. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000; 215:631-5.
  1. Westcott J, Davis SD, Fleishon H, Gefter WB, Henschke CI, McLoud TC, Pugatch RD, Sostman HD, Tocino I, White CS, Yankelevitz D, Bode FR, Goodman N. Rib fractures. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000; 215:637-9.
  1. Westcott J, Davis SD, Fleishon H, Gefter WB, Henschke CI, McLoud TC, Pugatch RD, Sostman HD, Tocino I, White CS, Yankelevitz D, Bode FR. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000; 215:641-3.
  1. Westcott J, Davis SD, Fleishon H, Gefter WB, Henschke CI, McLoud TC, Pugatch RD, Sostman HD, Tocino I, White CS, Yankelevitz D, Bode FR. Acute respiratory illness. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000; 215:645-8.
  1. Westcott J, Davis SD, Fleishon H, Gefter WB, Henschke CI, McLoud TC, Pugatch RD, Sostman HD, Tocino I, White CS, Yankelevitz D, Bode FR. Acute respiratory illness in HIV-positive patients. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000; 215:649-53.
  1. Davis SD, Westcott J, Fleishon H, Gefter WB, Henschke CI, McLoud TC, Pugatch RD, Sostman HD, Tocino I, White CS, Yankelevitz DF, Bode FR. Screening for pulmonary metastases. ACR Appropriateness Criteria. Radiology 2000; 215(suppl):655-62.
  1. Yankelevitz DF, Reeves AP, Kostis WJ, Zhao B, Henschke CI. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology. 2000; 217:251-6.
  1. Henschke CI. Early lung cancer action project: findings on baseline and annual repeat screening. Proceedings of an International Expert Meeting on New Advances in Radiology and Screening of Asbestos-Related Diseases. Finnish Institute of Occupational Health. Feb 9-11, 2000.
  1. Wisnivesky JP, Kaplan J, Henschke CI, McGinn T, Crystal RG. Evaluation of clinical parameters to predict Mycobacterium tuberculosis in inpatients. Arch Intern Med 2000; 160:2471-6.
  2. Yankelevitz DF, Wisnivesky JP, Henschke CI. Comparison of biopsy techniques in assessment of solitary pulmonary nodules. Semin Ultrasound CT MRI 2000; 21:139-48.
  1. Henschke CI. Early Lung Cancer Action Project: Annual Screening with Single-Section Helical CT. Categorical Course in Diagnostic Radiology: Thoracic Imaging – Chest and Cardiac (editors: NL Mueller, TM Grist) Radiological Society of North America 2001.
  1. Henschke CI, Yankelevitz DG, Libby DM, McCauley D, Pasmantier M, Altorki NK, Smith JP, Miettinen OS. Early Lung Cancer Action Project: Annual Screening Using Single-Slice Helical CT. Ann N Y Acad Sci. 2001; 952:124-34.
  1. Miettinen OS, Henschke CI. CT Screening for Lung Cancer: Coping with nihilistic recommendations. Radiology 2001; 221:592-6.
  1. Miettinen OS, Yankelevitz DF, Henschke CI. Screening for lung cancer. N Engl J Med 2001; 344:935.
  1. Henschke CI, Naidich DP, Yankelevitz DF, McGuinness G, McCauley DI, Smith JP, Libby D, Pasmantier M, Vazquez M, Koizumi J, Flieder D, Altorki N, Miettinen OS. Early Lung Cancer Action Project: initial findings on repeat screenings. Cancer 2001; 92:153-9.
  1. Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS, Libby D, Pasmantier M, Koizumi J, Altorki N, Smith JP. Early Lung Cancer Action Project: a summary of the findings on baseline screening. Oncologist 2001; 6:147-52.
  1. Hillerdal G, Henschke C, Sone S. Screening foer lung cancer – helt nya moejligheter med nya metoder. [Screening for lung cancer- new possibilities with new methods!]. Laekartidningen 2001; 98:2047-51.
  1. Ostroff JS, Buckshee N, Mancuso CA, Yankelevitz DF, Henschke CI. Smoking cessation following CT screening for early detection of lung cancer. Preventive Medicine 2001; 33:613-21.
  1. Miettinen OS, Henschke CI. Commentary on CT screening for lung cancer: not ready for routine practice. Radiology 2001; 221:598-9.
  1. Gorlova OY, Kimmel M, Henschke C. Modeling of long-term screening for lung carcinoma. Cancer 2001; 92:1531-40 PMID:11745232.
  1. Shaham D, Goitein O, Vazquez MF, Libson E, Sherman Y, Henschke CI, Yankelevitz DF. Biopsy of mediastinal tumors: needle biopsy versus mediastinoscopy. J Bronchol 2001; 8:132-8.
  1. Mirtcheva RM, Vazquez M, Yankelevitz DF, Henschke CI. Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar features presenting as ground-glass opacities on CT. Clin Imaging 2002; 26:95-100 PMID:11852215.
  1. Yankelevitz DF, Henschke CI. Computed tomography screening for lung cancer. Oncology Spectrums 2002; 3:110-15.
  1. Henschke CI, Yankelevitz DF, McCauley D, Libby D, Pasmantier M, Smith JP. CT Screening for lung cancer. Clinics in Chest Medicine. 2002; 49-57.
  1. Henschke CI. Mammography screening for breast cancer: the data behind the debate. Medical Crossfire. 2002;1-8.
  2. Shaham D, Goitein O, Yankelevitz DF, Vazquez M, Reeves AP, Henschke CI. Screening for lung cancer using low-radiation dose computed tomography. Imaging Decisions. 2002; 6:4-13.
  3. Henschke CI, Yankelevitz DF, McCauley D, Libby D, Pasmantier M, Smith JP. CT screening for lung cancer. Cancer Chemother Biol Response Modif. 2002; 20:665-76.
  1. Henschke CI, Yankelevitz DF, Smith JP, Miettinen OS. Screening for lung cancer: the early lung cancer action approach. Lung Cancer 2002; 35:143-8.
  1. Miettinen OS, Henschke CI, Pasmantier MW, Smith JP, Libby DM, Yankelevitz DF. Mammographic screening: no reliable supporting evidence? The Lancet 2002; 359:404-5 PMID:11844515.
  1. Miettinen OS, Henschke CI, Pasmantier MW, Smith JP, Libby DM, Yankelevitz DF. Mammographic screening: No reliable supporting evidence? The Lancet 2002; 359:9307- P706.
  1. Miettinen OS, Henschke CI. Method appears appealing but analysis is flawed. Lancet 2002; 309:706.
  1. Henschke CI, Yankelevitz DF, Mirtcheva R, McGuinness G, McCauley D, Miettinen OS, ELCAP Group. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002; 178:1053-7 PMID:11959700.
  1. Miettinen OS, Henschke CI. Authors’ reply. Lancet 2002; 354:1205.
  1. Hirsch FR, Bunn PA, Dmitrowsky E, Field JKF, Franklin WA, Greenberg RE, Hansen HH, Henschke CI, Rigas JR, Smith RA, Toennesen P, Mulshine JL. 4th international conference on prevention and early detection of lung cancer. Reykjavik, Iceland. August 9-12, 2001. Lung Cancer 2002; 37:325.
  1. Henschke CI, Yankelevitz DF, McCauley DI, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. The use of spiral CT in screening for lung cancer. Japanese Journal of Lung Cancer Clinics 2002; 5:7-11.
  1. Field JK, Brambilla C, Caporaso N, Flahault A, Henschke C, Herman J, Hirsch F, Lachmann P, Lam S, Maier S, Montuenga LM, Mulshine J, Murphy M, Pullen J, Spitz M, Tockman M, Tyndale R, Wistuba I, Youngson J. Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations. International Journal of Oncology 2002; 21:369-73.
  1. Miettinen OS, Henschke CI. Author’s reply. Lancet 2002; 360:719.
  1. Miettinen OS, Henschke CI. Response to letters. Lancet 2002; 360:1979.
  1. NY-ELCAP investigators. Response to Tobacco money: up in smoke? Lancet 2002; 360:1980-1.
  1. Shaham D, Goitein O, Henschke CI. Screening for lung cancer using low-dose computed tomography. Medicina Thoracalis 2002; 55:167-71 (Hungarian).
  1. Henschke CI, Yankelevitz DF, Libby D, Kimmel M. CT screening for lung cancer: the first ten years. The Cancer Journal 2002; 8:47-54.
  1. Henschke CI, Yankelevitz DF, Libby D, McCauley D, Pasmantier M, Smith JP. Computed tomography screening for lung cancer. Clin Chest Med 2002; 23:49-57.
  2. Henschke CI, Yankelevitz DF. Early Lung Cancer Action Project: Annual CT screening for Lung Cancer. Lung Cancer Updates (eds. D. Johnson and H. Pass) 2002; 2:1-6.
  3. Henschke CI, Wisnivesky JP, Yankelevitz DF, Miettinen OS. Screen-diagnosed small stage I cancers of the lung: genuineness and curability. Lung Cancer 2003; 39:327-30.
  1. Henschke CI, Yankelevitz DF, McCauley DI, Libby DM, Pasmantier MW, Smith JP. Guidelines for the use of spiral computed tomography in screening for lung cancer. European Respiratory Journal 2003; 21; Suppl 39:45s-51s.
  1. Henschke CI. Just What the Patient Ordered? Debating the Value of Unprescribed Full-Body CT Scans. Medical Crossfire 2003; 5:24-8.
  1. Henschke CI, Yankelevitz DF, Kostis WJ. CT screening for lung cancer. Semin Ultrasound, CT and MRI 2003; 24:23-32.
  1. Henschke CI, Shaham D, Farooqi A, Yankelevitz DF. Computerized tomography screening for lung cancer: new findings and diagnostic work-up. Seminars in Thoracic and Cardiovascular Surgery 2003; 15:397-404.
  1. Yankelevitz DF, Kostis WF, Henschke CI, Heelan RT, Libby DM, Pasmantier MW, Smith JP. Overdiagnosis in chest radiographic screening for lung carcinoma: Frequency. Cancer 2003; 97:1271-5.
  1. Vazquez M, Flieder D, Travis W, Carter D, Yankelevitz D, Miettinen OSM, Henschke CI. Early Lung Cancer Action Project Pathology Protocol. Lung Cancer 2003; 39:231-32.
  1. Henschke CI. A defense of the New York Early Lung Cancer Action Project. Lancet 2003; 361:18.
  1. Wisnivesky JP, Mushlin A, Sicherman N, Henschke CI. Cost-effectiveness of baseline low-dose CT screening for lung cancer: preliminary results. Chest 2003; 124:614-21.
  1. Henschke CI. Editorial on Lung Cancer Screening: A Different Paradigm. American Review of Respiratory Diseases and Critical Care Medicine 2003; 168:1143-4.
  1. Kostis WJ, Reeves AP, Yankelevitz DF, Henschke CI. Three-dimensional segmentation and growth-rate estimation of small pulmonary nodules in helical CT images. IEEE Transaction on Medical Imaging. 2003; 22:1259-74.
  1. Miettinen OS, Yankelevitz DF, Henschke CI. Evaluation of screening for a cancer: annotated catechism of the Gold Standard creed. Journal of Evaluation in Clinical Practice. 2003; 9:145-50.
  1. Gorlova OY, Amos C, Henschke CI, Lei L, Spitz M, Wei Q, Wu X, Kimmel M. Genetic susceptibility for lung cancer: interactions with gender and smoking history and impact on early detection policies. Human Heredity. 2003; 56:139-45.
  1. Kostis WJ, Fluture SC, Farooqi AO, Yankelevitz DF, Henschke CI. Volumetric assessment of emphysema on low-dose screening CT scans. SPIE Medical Imaging. 2003; 5032:827-34.
  1. Kostis WJ, Fluture S, Yankelevitz DF, Henschke CI. Method for analysis and display of distribution of emphysema in CT scans. SPIE Medical Imaging. 2003; 5032:199-206.
  1. Henschke CI, Miettinen OS. Women’s susceptibility to tobacco carcinogens. Lung Cancer. 2004; 43:1-5.
  2. Henschke CI, Yankelevitz DF, Naidich DP, McCauley DI, McGuinness G, Libby DM, Smith JP, Pasmantier MW, Miettinen OS. CT screening for lung cancer: Suspiciousness of nodules according to size on baseline scans. Radiology 2004; 231:164-8.
  3. Kostis WJ, Yankelevitz DF, Reeves AP, Fluture SC, Henschke CI. Small pulmonary nodules: reproducibility of three-dimensional volumetric measurement and estimation of time to follow-up CT. Radiology 2004; 231:446-52.
  1. Libby D, Smith JP, Altorki K, Pasmantier MW, Yankelevitz DF, Henschke CI. Managing the small pulmonary nodule discovered by computed tomography. Chest. 2004; 125:1522-9.
  1. Wisnivesky JP, Yankelevitz DF, Henschke CI. The effect of tumor size on curability of stage I non-small-cell lung cancers. Chest. 2004; 126:761-5.
  1. Armato SG 3rd, McLennan G, McNitt-Gray MF, Meyer CR, Yankelevitz D, Aberel DR, Henschke CI, Hoffman EA, Kazerooni EA, MacMahon H, Reeves AP, Croft BY, Clarke LP. Lung Image Database Consortium Research Group(LIDC). Developing a resource for the medical imaging research community. Radiology. 2004; 232:739-48.
  1. Henschke CI, Yankelevitz DF, Kostis WJ. Lungenkrebsscreening? Radiologe. 2004; 44:541-4.
  1. Henschke CI, Yankelevitz DF, Smith JP, Libby D, Pasmantier MW, McCauley CI, McGuinness G, Naidich DP, Farooqi A, Vazquez M, Miettinen OS. CT Screening for Lung Cancer: Assessing a regimen’s diagnostic performance. Clinical Imaging. 2004; 28:317-21.
  1. Yankelevitz D, Henschke CI. State-of-the-art screening for lung cancer (part 2): CT scanning. Thorac Surg Clin. 2004; 14:53-9.
  1. Henschke CI, Yankelevitz DF. The path to progress in lung cancer screening. Commentary on Systems engineering lung cancer screening with spiral CT: How could it work? Oncology. 2004.
  1. Henschke CI, Shaham D, Brambilla E, Yankelevitz DF, Reeves AP, Yip R, Kramer A, Brambilla C, Sone S. An update on CT screening for lung cancer. European Respiratory Monograph. 2005:9.
  1. Henschke CI, Shaham D, Yankelevitz DF, Altorki NK. CT screening for lung cancer: past and ongoing studies. Semin Thorac Cardiovasc Surg. 2005; 17:99-106.
  1. Gorlova O, Peng B, Yankelevitz D, Henschke CI, Kimmel M. Estimating the growth rates of primary lung tumors from samples with missing measurements. Statistics in Medicine. 2005; 24:1117-34.
  1. Altorki NK, Yankelevitz DF, Vazquez MF, Kramer A, Henschke CI. Bronchioloalveolar carcinoma in small pulmonary nodules: clinical relevance. Seminars of Cardiothoracic Surgery. 2005; 17:123-7.
  1. Cham M, Yankelevitz DF, Henschke CI. Thromboembolic disease detection at indirect CT venography versus CT pulmonary angiography. Radiology. 2005; 234:591-4.
  1. Chapman BE, Yankelevitz DF, Henschke CI, Gur D. Simulations of the effect of imperfect detection on the temporal dynamics of a lung cancer screening program. Radiology. 2005; 234:582-90.
  1. Yankelevitz DF, Wisnivesky JP, Henschke CI. Stage of lung cancer in relation to its size. part 1. Chest. 2005; 127:1132-5 PMID:15821185.
  2. Wisnivesky JP, Yankelevitz DF, Henschke CI. Stage of lung cancer in relation to its size. part 2. Chest. 2005; 127: 127:1136-9.
  1. Wisnivesky JP, Henschke C, Balentine J, Willner C, Deloire AM, McGinn TG. Prospective validation of a prediction model for isolating inpatients with suspected pulmonary tuberculosis. Archives of Internal Medicine. 2005; 165:453-7.
  1. Wisnivesky JP, Henschke C, McGinn T, Iannuzzi MC. Prognosis of Stage II non-small cell lung cancer according to tumor and nodal status at diagnosis. Lung Cancer. 2005; 49:181-6.
  1. Henschke CI, Austin JHM, Bauer T, et al. Minority Opinion: CT screening for lung cancer. J Thoracic Imaging. 2005; 20:324-5.
  1. Henschke CI. The news you haven’t heard about lung cancer. Bottom Line/Health. Oct. 2005.
  1. Lynch TJ, Bogard JA, Curran WJ Jr, DeCamp MM, Gandara DR, Goss G, Henschke CI, Jett JR, Johnson BE, Kelly KL, LeChevalier T, Mulshine JL, Scagliotti GV, Schiller JH, Shaw A, Thatcher N, Wokes EE, Wood DE, Hart C. Early stage lung cancer, new approaches to evaluation and treatment: conference summary statement. Clinical Cancer Research. 2005; 1:4981s-3s.
  1. Henschke CI. CT Screening for Lung Cancer: Principles and Results. 2004 Conference Proceedings, Boston MA. Clinical Cancer Research. 2005; 11:4984s-4987s.
  1. Wisnivesky JP, McGinn T. Henschke CI, Iannuzzi MC, Halm EA. Ethnic disparities in the treatment of Stage I non-small cell lung cancer. American Journal of Respiratory and Critical Care Medicine. 2005; 171:1158-1163.
  1. Henschke CI, International Early Lung Cancer Program Investigators. CT Screening for Lung Cancer: update 2005. Surg Oncol Clin N Am 2005; 14:761-76.
  1. International Early Lung Cancer Program Investigators. An Update of CT screening for lung cancer. Seminars in Ultrasound, CT and MR. 2005; 26:438-56.
  1. Henschke CI, Yankelevitz DF. CT screening. Medical Radiology. Diagnostic Imaging. Springer Verlag, 2005.
  1. Henschke CI, Yankelevitz DF, Miettinen OI, The International Early Lung Cancer Action Program Investigators. CT Screening for Lung Cancer: The relationship of disease stage to tumor size. Archives of Internal Medicine. 2006; 166: 321-5.
  1. Reeves A, Chan A, Yankelevitz D, Henschke C, Kessler B, Kostis WJ. On measuring the change in size of pulmonary nodules. IEEE Transactions on Medical Imaging. 2006; 25:433-450.
  1. Libby D, Wu N, Lee I, Farooqi A Smith JP, Pasmantier MW, McCauley D, Yankelevitz DF, Henschke CI. CT Screening for Lung Cancer: the value of short-term CT follow-up. Chest 2006; 129:1039-42.
  1. Kostis WJ, Reeves AP, Yankelevitz DF, Henschke CI. Three-dimensional morphometry of small pulmonary nodules in helical CT images. IEEE Transaction on Medical Imaging. 2006; 25:435-50.
  1. Henschke CI, Shaham D, Yankelevitz DF, Carter D, Vazquez M, Kostis WJ, Reeves AP, Kramer A, Miettinen OS. CT Screening for Lung Cancer: Significance of diagnoses in the baseline cycle of screening. Clinical Imaging 2006; 30:11-5.
  2. Shemesh J, Henschke CI, Farooqi A, Yip R, Yankelevitz DF, Shaham D, Miettinen OS. Frequency of coronary artery calcification on low-dose computed tomography screening for lung cancer. Clinical Imaging 2006; 30:181-5.
  1. Henschke CI, Lee I, Wu N, Farooqi A, Yankelevitz DF, Khan A, Altorki NK, ELCAP and NY-ELCAP Investigators. CT Screening for Lung Cancer: Prevalence and Incidence of Mediastinal Masses. Radiology 2006; 239:586-90.
  1. Flieder DB, Vazquez M, Carter D, Brambilla E, Gazdar A, Noguchi M, Travis WD, Kramer A, Yankelevitz DF, Henschke CI. Pathologic findings of lung tumors diagnosed on baseline CT screening. American Journal of Surgical Pathology 2006; 30:606-13.
  1. Henschke CI, Yip R, Yankelevitz DF, Miettinen OS. CT screening for lung cancer: prospects of surviving competing causes of death. Clinical Lung Cancer 2006; 7:323-5.
  1. Field JK, Smith RA, Duffy SW, Berg CD, van Klaveren R, Henschke CI, Carbone D, Postmus PI, Paci E, Hirsch FR, Mulshine JL. The Liverpool statement 2005: priorities for the EU/US spiral CT Collaborative Group. J of Thoracic Oncology 2006; 1:497-8.
  1. International Early Lung Cancer Action Program Investigators, Henschke CI, Yip R, Miettinen OI. Women’s susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. JAMA 2006; 296:180-4.
  1. PIOPED II Investigators. Multidetector computed tomography for acute pulmonary embolism.  NEJM 2006; 354:2317-27 PMID:16738268.
  1. Wisnivesky JP, Henschke CI, Yankelevitz DF. Diagnostic percutaneous transthoracic needle biopsy does not affect survival of Stage I lung cancer. American Journal of Respiratory and Critical Care Medicine 2006; 170:684-8.
  1. The International Early Lung Cancer Action Program Investigators. Survival of Patients with Stage I lung cancer detected on CT screening. N Engl J of Med 2006; 355:1763-71.
  1. Miettinen OS, Henschke CI. Response to letters to the editor. JAMA 2006; 296:218-9.
  1. Henschke CI, Smith JP, Miettinen OS. Answers to letters. NEJM 2007; 356:743-7.
  1. NY-ELCAP Investigators. CT Screening for Lung Cancer: diagnoses resulting from the New York Early Lung Cancer Action Project. Radiology 2007; 243:239-49.
  1. Henschke CI, Yankelevitz DF, Altorki NK. The role of CT screening for lung cancer. Thorac Surg Clin 2007; 17:137-42.
  1. Yankelevitz DF, Cham MD, Farooqi AO, Henschke CI. CT directed diagnosis of peripheral lung lesions suspicious for cancer. Thorac Surg Clin 2007; 17:143-58.
  1. Henschke CI. CT screening for lung cancer. American Journal of Hematology/Oncology 2007; 6; 21-3.
  1. Carter D, Vazquez M, Flieder DB, Brambilla E, Gazdar A, Noguchi M, Travis WD, Kramer A, Yip R, Yankelevitz DF, Henschke CI, ELCAP and NY-ELCAP Investigators. Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening. Lung Cancer 2007; 56:193-9.
  1. Henschke CI, Yankelevitz DF, Smith JP, Miettinen OS. Computed Tomography for Lung Screening for Lung Cancer. JAMA 2007; 298:514-5.
  1. Henschke CI. CT screening for lung cancer. Clinical Cancer Research 2007; 13:4949-50.
  1. Henschke, CI. Editorial: CT screening for lung cancer is justified. Nat Clin Pract Oncol. 2007 Aug; 4:440-1. Epub 2007 Jun 12.
  1. Henschke CI, Smith JP, Miettinen OS. Letter to the editor. JAMA 2007; 298;514-5.
  1. Armato SG 3rd, McNitt-Gray MF, Reeves AP, Meyer CR, McLennan G, Aberle DR, Kazerooni EA, MacMahon H, van Beek EJ, Yankelevitz D, Hoffman EA, Henschke CI, Roberts RY, Brown MS, Engelmann RM, Pais RC, Piker CW, Qing D, Mocherginsky M, Croft BY, Clarke LP. The Lung Image Database Consortium (LIDC): An evaluation of radiologist variability in the identification of lung nodules in CT scans. Academic Radiology 2007; 14:1409-21.
  1. Enquobahrie AA, Reeves AP, Yankelevitz DF, Henschke CI. Automated detection of small solid pulmonary nodules in whole lung CT scans from a lung cancer screening study. Academic Radiology 2007; 14:579-93.
  1. International Early Lung Cancer Action Program Investigators. Computed tomographic screening for lung cancer: individualizing the benefit of the screening. European Respiratory Journal 2007; 30:843-7.
  1. Reeves AP, Biancardi AM, Apanasovich TV, Meyer CR, MacMahon H, van Beek EJ, Kazerooni EA, Yankelevitz D, McNitt-Gray MF, McLennan G, Armato SG, Aberle DR, Henschke CI, Hoffman EA, Croft BY, Clarke LP. The Lung Image Database Consortium (LIDC): a comparison of different size metrics for pulmonary nodule measurements. Academic Radiology 2007; 14:1475-85 PMID:18035277 PMCID: PMC2222556.
  1. Browder WA, Reeves AP, Apanasovich TV, Cham MD, Yankelevitz DF, Henschke CI. Automated volumetric segmentation method for growth consistency of nonsolid pulmonary nodules in high-resolution CT. Proceedings of the SPIE 2007, Volume 6514, pp. 65140Y1-10.
  1. Vazquez MF, Koizumi JH, Henschke CI, Yankelevitz DF. Reliability of cytological diagnosis of early lung cancer. Cancer and Cancer Cytopathology 2007; 111:252-8 PMID:17614298.
  1. Weinsaft JW, Cham MD, Janik M, Min JK, Henschke CI, Yankelevitz DF, Devereux RB. Left ventricular papillary muscles and trabeculae are significant determinants of cardiac MRI volumetric measurements: effects on clinical standards in patients with advanced systolic dysfunction. Int J Cardiol 2008; 126:359-65.
  1. Saqi A, Shaham D, Scognamiglio T, Murray MP, Henschke CI, Yankelevitz D, Vazquez MF. Incidence and cytological features of pulmonary hamartomas indeterminate on CT scans. Cytopathology 2008; 19:185-91.
  1. Zudaire I, Lozano MD, Vazquez MF, Pajares MJ, Agorreta J, Pio R, Zulueta JJ, Yankelevitz DF, Henschke CI, Montuenga LM. Molecular characterization of small peripheral lung tumors based on the analysis of fine needle aspirates. Histol Histopathol 2008; 23:33-40.
  1. Henschke CI. CT screening for lung cancer. N Engl J of Med Watch Oncology 2008.
  1. Henschke CI, Yankelevitz DF. CT screening for lung cancer: Update 2007. The Oncologist 2008; 13:65-78 PMID:18245013.
  2. Huang Y, Shaham D, Austin JH, Yankelevitz DF, Henschke CI; I-ELCAP Investigators. Pulmonary lymphoma identified as a result of low-dose CT screening for lung cancer. Clin Imaging 2008; 32:264-8.
  3. Gill RK, Vazquez MF. Kramer A, Hames M, Zhang L, Heselmeyer-Haddad K, Ried T, Ghilo K, Henschke CI, Yankelevitz DF, Jen J. The use of genetic markers to identify lung cancer in fine needle aspiration samples. Clin Cancer Res 2008; 14:7481-7.
  1. Cham MD, Lane ME, Henschke CI, Yankelevitz DF. Lung biopsy: special techniques. Semin Respir Crit Care Med 2008; 29:335-49.
  1. Lee J, Reeves AP, Yankelevitz DF, Henschke CI. Skewness Reduction Approach for Measuring Airway Wall Thickness. International Journal of Computer Assisted Radiology and Surgery 2008; 3: S50-S52.
  1. Vazquez M, Carter D, Brambilla E, Gazdar A, Noguchi M, Travis W, Huang Y, Zhang L, Yip R, Yankelevitz DF,  Henschke CI.  Solitary and Multiple Resected Adenocarcinomas after CT Screening for Lung Cancer: histopathologic features and their prognostic implications. Lung Cancer 2009; 64:148-54.
  1. Jirapatnakul AC, Reeves AP, Zhang L, Biancardi AM, Yankelevitz DF, Henschke CI. Semi-automated measurement of pulmonary nodule growth without explicit segmentation. Biomedical Imaging: from Nano to Maco. IEEE 2009: 855-8.
  1. Lee J, Reeves AP, Yankelevitz DF, Henschke CI. Bronchial Segment Matching in Low-dose Lung CT Scan Pairs. SPIE Medical Imaging. March 3, 2009; 7260:72600A.
  1. Keller BM, Reeves AP, Apanosovich TV, Wang J, Yankelevitz DF, Henschke CI. Quantitative assessment of emphysema from whole lung CT scans: comparison with visual grading.  SPIE Medical Imaging. February 27, 2009; 7260:726008.
  1. Jirapatnakul AC, Fotin SV, Reeves AP, Biancardi AM, Yankelevitz DF, Henschke CI. Automated nodule location and size estimation using a multi-scale Laplacian of Gaussian filtering approach. IEEE 2009: 1028-31.
  1. Keller BM, Reeves AP, Yankelevitz DF, Henschke CI, Graham Barr R. Emphysema Quantification from CT Scans Using Novel Application of Diaphragm Curvature Estimation: Comparison with Standard Quantification Methods and Pulmonary Function Data. SPIE Medical Imaging February 27, 2009; 7260:726032.
  1. Jirapatnakul AC, Reeves AP, Biancardi AM, Yankelevitz DF, Henschke CI. Identification of asymmetric pulmonary nodule growth using a moment-based algorithm. SPIE Medical Imaging February 27, 2009; 7260:72602W.
  1. Jirapatnakul AC, Reeves AP, Biancardi AM, Yankelevitz DF, Henschke CI. Improved precision of repeat image change measurement of pulmonary nodules using moment-based z-compensation on a zero-change dataset. SPIE Medical Imaging March 3, 2009; 7260:72601P.
  1. Fotin SV, Reeves AP, Biancardi AM, Yankelevitz DF, Henschke CI. A multiscale Laplacian of Gaussian filtering approach to automated pulmonary nodule detection from whole-lung low-dose CT scans. SPIE Medical Imaging March 3, 2009; 7260:72601Q.
  1. Anderson CM, Yip R, Henschke CI, Yankelevitz DF, Ostroff JS, Burns DM. Smoking cessation and relapse during a lung cancer screening program.  Cancer Epidemiol Biomarkers Prev 2009; 18: 3476-83.
  2. Lee J, Biancardi AM, Reeves AP, Yankelevitz DF, Henschke CI. Estimation of the anatomical locations using standard frame of reference in chest CT scans. Annu Eng Conf IEEE Med Biol Soc. 2009; 5809-5812.
  1. Henschke CI, Yip R, Yankelevitz DF. CT Screening for Lung Cancer: Update 2008. Japanese Lung Cancer Society. 2009.
  1. Fotin SV, Reeves AP, Biancardi AM, Yankelevitz DF, Henschke CI. Standard moments based vessel bifurcation filter for computer-aided detection of pulmonary nodules. In Medical Imaging 2010: Computer-aided diagnosis. 2010: 7624: 76413.
  1. Zhang L, Yankelevitz DF, Henschke CI, Reeves AP, Vazquez MF, Carter D. Variation in vascular distribution in small lung cancers. Lung Cancer 2010; 68:389-93.
  1. Zhang L, Yankelevitz DF, Henschke CI, Jirapatnakul A, Reeves AP, Carter D. Zone of transition: a potential source of error in tumor volume estimation. Radiology 2010; 256: 633-9.
  1. Shaham D, Yankelevitz DF, Vazquez M, Bogot N, Henschke CI. CT features of intrapulmonary lymph nodes confirmed by cytology. Clinical Imaging 2010; 34:185-90.
  1. Wisnivesky JP, Henschke CI, Swanson S, Yankelevitz DF, Zulueta J, Marcus S, Halm EA. Limited resection for the treatment of patients with stage IA lung cancer. Annals of Surgery 2010; 251: 550-4.
  2. Shemesh J, Henschke CI, Shaham D, Yip R, Farooqi AO, Cham MD, McCauley DI, Chen M, Smith JP, Libby DM, Pasmantier MW, Yankelevitz DF. Ordinal scoring of coronary artery calcifications on low-dose CT scans of the chest predicts deaths from cardiovascular disease. Radiology 2010; 257; 541-8. Accompanied by an editorial by Lee CI and Forman HP. Radiology 2010; 257:31-314.
  1. Zulueta J, Reeves AP, Yankelevitz DF, Henschke CI. Lung Cancer, Diagnostic Imaging and Chronic Obstructive Pulmonary Disease. Lung Health Professional 2011; 2:20-23 (and also translated into Spanish).
  1. Henschke CI. Is CT screening for lung cancer ready for prime time? Journal of Thoracic Imaging 2011; 26:5-6 (One of 10 most accessed articles in 2011).
  1. Huang Y, Xu DM, Jirapatnakul J, Reeves AP, Farooqi A, Zhang LJ, Giunta S, Zulueta J, Aye R, Miller A, Mendelson DS, Aylesworth C, Sheppard B, Klingler K, Yankelevitz DF, Henschke CI. CT and computer-based features of small hamartomas. Clinical Imaging 2011; 35:116-22.
  1. Henschke CI, Boffetta P, Gorlova OY, Yip R, Delancey J, Foy M. Assessment of Lung-cancer Mortality Reduction from CT Screening. Lung Cancer 2011; 71:328-32.
  1. Armato SG 3rd, McLennan G, Bidaut L, McNitt-Gray MF, Meyer CR, Reeves AP, Zhao B, Aberele DR, Henschke CI, Hoffman EA, Kazerooni EA, MacMahon H, van Beek EJ, Yankelevitz D, Biancardi AM, Bland PH, Brown MS, et al. The Lung Image Database Consortium (LIDC) and Image Database Resource Initiative (IDRI): A completed reference database of lung nodules on CT scans. Med Phys 2011; 36:915-31.
  1. Henschke CI, Yankelevitz DF, Reeves AP, Cham MD. Image analysis of small pulmonary nodules identified by computed tomography. Mount Sinai Journal of Medicine 2011; 78:882-93.
  1. Foy M, Yip R, Chen X, Kimmel M, Gorlova OY, Henschke CI. Modeling the mortality reduction due to CT screening for lung cancer. Cancer 2011; 117:2703-8.
  2. Foos DH, Yankelevitz DF, Wang X, Berlin D, Zappetti D, Cham M, Sanders A, Parker KV, Henschke CI. Improved visualization of tubes and lines I portable intensive care unit radiographs: a study comparing a new approach to the standard approach. Clin Imag 2011; 35:346-52.
  3. Wildstein KA, Faustini Y, Yip R, Henschke CI, Ostroff J. Longitudinal predictors of adherence to annual follow-up in a lung cancer screening program. Journal of Medical Screening 2011; 18:154-60.
  1. Loukeris K, Vazquez MF, Sica F, Wagner P, Henschke C, Yankelevitz D, Cham MD, Saqi A.. Cytological Cell Blocks: Predictors of squamous cell carcinoma and adenocarcinoma subtypes. Diagnostic Pathology 2012; 40:380-7.
  1. Henschke CI. Re: inconsistencies in findings from the early lung cancer action project studies of lung cancer screening. J Natl Cancer Inst 2012: 104:254-5.
  1. Zhang L, Yankelevitz DF, Carter D, Henschke CI, Yip R, Reeves AP. Internal growth of nonsolid nodules: radiological-pathologic correlation. Radiology 2012; 263:279-86.
  1. Zulueta J, Wisnivesky JP, Henschke CI, Yip R, Farooqi AO, McCauley DI, Chen M, Libby DM, Smith JP, Pasmantier MW, Yankelevitz DF. Emphysema scores predict death from COPD and lung cancer. Chest 2012; 141:1216-23.
  1. Austin JH, Yip R, D’Souza BM, Yankelevitz DF, Henschke CI for the I-ELCAP Investigators. Small-cell carcinoma of the lung detected by CT screening: stage distribution and curability. Lung Cancer 2012; 76:339-43.
  1. Henschke CI. Expert Opinion: barriers to CT screening for lung cancer. J Thor Imaging 2012; 27:208.
  1. Henschke CI, Yankelevitz DF, Yip R, Reeves AP, Farooqi A, Xu D, Smith JP, Libby DM, Pasmantier MW, Miettinen OS. As the Writing Committee for the I-ELCAP Investigators. Lung cancers diagnosed at annual CT Screening: Volume Doubling Times. Radiology 2012; 263:578-83.
  1. Gelbman BJ, Cham MD, Kim W, Libby DM, Smith JP, Port JL, Altorki NK, Henschke CI, Yankelevitz DF. Radiographic and clinical characterization of false negative results from CT-guided needle biopsies of lung nodules. J Thorac Oncol 2012; 7:815-20.
  1. Farooqi AO, Cham M, Zhang L, Beasley MB, Austin JH, Miller A, Zulueta JJ, Roberts H, Esner C, Kao S, Thorsen MK, Smith JP, Libby DM, Yip R, Yankelevitz DF, Henschke CI for the I-ELCAP Investigators. Lung cancer associated with cystic airspaces. AJR Am J Roentgenol 2012: 199:781-6.
  1. Lee IJ, Henschke CI. Diagnostic differences between pulmonary actinomycosis and lung adenocarcinoma. Onkologie 2012; 35:553-4.
  1. Henschke CI, Yip R, Yankelevitz DF, Smith JP for the I-ELCAP Investigators. Definition of a positive test result in computed tomography screening for lung cancer: a cohort study. Annals of Internal Medicine 2013; 158:246-52.
  1. Henschke CI, Yankelevitz D. In memoriam: Joseph P. Whalen, M.D. Clin Imaging 2013 Nov-Dec; 37-981-2 PMID:24344395.
  1. Yankelevitz DF, Henschke CI, Yip R, Boffetta P, Shemesh J, Cham MD, Narula J, Hecht HS, FAMRI-IELCAP Investigators. Second-hand tobacco smoke in never smokers is a significant risk factor for coronary artery calcification. JACC Cardiovasc Imaging 2013; 6:651-7.
  2. Padgett J, Biancardi AM, Henschke CI, Yankelevitz DF, Reeves AP. Local noise estimation in low-dose chest CT images. Int J CARS 2014; 9:221-9.
  1. Salvatore M, Margolies L, Kale M, Wisnivesky J, Kotkin S, Henschke CI, Yankelevitz DF. Breast density: comparison of chest CT with mammography. Radiology 2014; 270:67-73.
  1. Miettinen OS, Henschke CI, Smith JO Yankelevitz DF. Is ground glass descriptive of a type of pulmonary nodule? Radiology 2014 Jan; 270:311-2.
  1. Altorki N, Yip R, Hanaoka T, Bauer T, Aye R, Kohman L, Sheppard B, Thurer R, Andaz S, Smith M, Mayfield W, Grannis F, Korst R, Pass H, Straznicka M, Flores R, Henschke CI for the I-ELCAP Investigators. Sublobar resection is equivalent to lobectomy for clinical Stage IA lung cancer in solid nodules. J Thorac Cardiovasc Surg 2014; 147:754-62; Discussion 762-4.
  1. Flores R, Bauer T, Aye R, Andaz S, Kohman L, Sheppard B, Mayfield W, Thurer R, Smith M, Korst R, Straznicka M, Grannis F, Pass H, Connery C, Yip R, Smith JP, Yankelevitz D, Henschke CI, Altorki N for the I-ELCAP Investigators. Balancing curability and unnecessary surgery in the context of CT screening for lung cancer. J Thorac Cardiovasc Surg 2014; 147:1619-26.
  1. Buckstein M, Yip R, Yankelevitz D, Henschke C, Rosenzweig K. Radiation therapy for Stage I lung cancer detected on computed tomography screening: results from the International Early Lung Cancer Action Program. J of Radiation Oncology 2014: 3:153-7.
  1. Xie Y. Htwe YM, Padgett J, Henschke CI, Yankelevitz DF, Reeves AP. Automated aortic calcification detection in low-dose chest CT images. SPIE Medical Imaging 2014; 9035:90250P.
  1. Xie Y, Cham M, Henschke CI, Yankelevitz DF, Reeves AP. Automated coronary artery calcification detection on low-dose chest CT images. SPIE Medical Imaging 2014; 9035:90250F.
  1. Xu DM, Yip R, Smith JP, Yankelevitz DF, Henschke CI. Retrospective review of lung cancers diagnosed in annual rounds of CT screening. Am J Roentgenol 2014; 203: 965-72.
  1. Black B, Szeinuk J, Whitehouse AC, Levin SM, Henschke CI, Yankelevitz DF, Flores RM. Rapid progression of pleural disease due to exposure to Libby amphibole: “Not your grandfather’s asbestos related disease.” Am J Ind Med 2014; 57: 1197-206.
  1. Xie Y, Cham M, Henschke CI, Yankelevitz DF, Reeves AP. Automated coronary artery calcification detection on low-dose chest CT images. SPIE International Symposium on Medical Imaging March 20, 2014.
  1. Xie Y, Htwe YM, Padgett J, Henschke CI, Yankelevitz DF, Reeves AP. Automated aortic calcification detection on low-dose chest CT images. SPIE International Symposium on Medical Imaging March 20, 2014.
  1. McAllister DA, Ahmed F, Austin JHM, Henschke CI, Keller BM, Lemeshow A, Reeves AP, Sonis Mesia-Vela, Pearson GDN, Shiau MC, Schwartz JE, Yankelevitz DF, Barr RG. Emphysema predicts hospitalization and incident airflow obstruction among older smokers: a prospective cohort study. PlosOne.
  2. Yip R, Henschke CI, Yankelevitz DF, Smith JP. CT screening for lung cancer: alternative definitions of positive test result based on the National Lung Screening Trial and International Early Lung Cancer Action Program databases. Radiology 2014; 273: 591-6.  Accompanied by a Radiology podcast.
  3. Pyenson BS, Henschke CI, Yankelevitz DF, Yip R, Dec E. Offering lung cancer screening to high-risk Medicare beneficiaries saves lives and is cost effective: an actuarial analysis. Am Health Drug Benefits 2014; 7: 272-82.
  1. Hecht HS, Henschke C, Yankelevitz D, Fuster V, Narula J. Combined detection of coronary artery disease and lung cancer. European Heart Journal 2014; 35:2792-6.
  1. Htwe Y, Chad MD, Henschke CI, Hecht, H. Shemesh J. Liang M, Tang W, Jirapatnakul A, Yip R, Yankelevitz DF. Coronary artery calcification on low-dose computed tomography: comparison of Agatston and Ordinal Scores. Clin Imaging. 2015; 39:799-802.
  1. International Early Lung Cancer Action Program Investigators (Yip R, Henschke CI, Yankelevitz DF, Boffetta P, Smith JP, writing committee). The impact of the regimen of screening on lung cancer cure: a comparison of I-ELCAP and NLST. European Journal of Cancer Prevention 2015; 24:201-8.
  1. Xu DM, Lee IJ, Zhao S, Yip R, Farooqi A, Cheung EH, Connery CP, Frumiento C, Glassberg RM, Herzog G, Peeke J, Scheinberg P, Shah P, Taylor J, Welch L, Widmann M, Yoder M, Yankelevitz DF, Henschke CI. CT screening for lung cancer: value of expert review of initial baseline screenings. Am J Roentgenol 2015; 204:281-6.
  1. Henschke CI, Yip R, Boffetta P, Markowitz S, Miller A, Hanaoka T, Zulueta JJ, Yankelevitz DF. CT screening for lung cancer: importance of emphysema for never smokers and smokers. Lung Cancer 2015; 88:42-7.
  1. Yankelevitz DF, Yip R, Smith JP, Liang M, Liu Y, Xu DM, Salvatore M, Wolf AS, Flores RM, Henschke CI for the IELCAP Investigators. CT screening for lung cancer: Nonsolid Nodules in Baseline and Annual Repeat Rounds. Radiology 2015; 277:555-64.
  1. Xie Y, Liang M, Yankelevitz DF, Henschke CI, Reeves AP. Automated segmentation of cardiac visceral fat in low-dose non-contrast chest CT images. SPIE Medical Imaging March 20, 2015; 9414:94140G.
  1. Henschke CI, Boffetta P, Yankelevitz DF, Altorki N. Computed tomography screening: the International Early Lung Cancer Program Experience. Thorac Surg Clin 2015; 25:129-43.
  1. Xie Y, Liang M, Yankelevitz DF, Henschke CI, Reeves AP. Automated measurement of pulmonary artery in low-dose non-contrast chest CT images. SPIE Medical Imaging March 20, 2015; 9414:94141G.
  1. Hecht HS, de Siqueira ME, Cham M, Yip R, Narula J, Fustre V, Henschke C, Yankelevitz D. Low- versus standard-dose coronary artery calcium scanning. European Heart Journal-Cardiovascular Imaging 2015; 16:358-63. Accompanied by editorial.
  1. Liu S, Salvatore M, Yankelevitz DF, Henschke CI, Reeves AP. Segmentation of Whole Breast from Low-dose Chest CT. SPIE Medical Imaging March 20, 2015; 9414:947140I.
  1. Margolies L, Salvatore M, Eber C, Jacobi A, Lee IJ, Liang M, Tang W, Xu D, Zhao S, Kale M, Wisnivesky J, Henschke CI, Yankelevitz D. The General Radiologist’s Role in Breast Cancer Risk Assessment: Breast Density Measurement on Chest CT. Clin Imaging 2015; 39:979-82.
  1. Ostroff JS, Copeland A, Borderud SP, Li Y, Shelley DR, Henschke CI. Readiness of lung cancer screening sites to deliver smoking cessation treatment: current practices, organizational priority and perceived barriers. Nicotine Tob Res 2016; 18:1067-75.
  2. Margolies L, Salvatore M, Hecht HS, Kotkin S, Yip R, Baber U, Bishay V, Narula J, Yankelevitz D, Henschke C. Digital Mammography and Screening for Coronary Artery Disease. JACC Cardiovasc Imaging 2016; 9:350-60.
  1. Salvatore M, Henschke CI, Yip R, Jacobi A, Eber C, Padilla M, Knoll A, Yankelevitz D. JOURNAL CLUB: Evidence of Interstitial Lung Disease on Low-Dose Chest CT: Prevalence, Patterns and Progression. AJR AM J Roentgenol 2016: 206:487-94.
  2. Taioli E, Yip R, Olkin I, Wolf A, Nicastri D, Henschke CI, Yankelevitz DF, Pass H, Flores RM. Survival after Sub-lobar Resection for Early-Stage Lung Cancer: Methodologic Obstacles in Comparing the Efficacy to Lobectomy. J Thorac Oncol 2016; 11:400-6.
  3. Yip R, Wolf A, Tam K, Taioli E, Olkin I, Flores RM, Yankelevitz DF, Henschke CI. Outcomes of lung cancers manifesting as nonsolid nodules. Lung Cancer 2016; 97:35-42.
  1. Henschke CI, Yip R, Wolf AS, Flores RM, Liang M, Salvatore MM, Liu Y, Xu DM, Smith JP, Yankelevitz DF for the IELCAP Investigators. CT Screening for Lung Cancer: Part-Solid Nodules in Baseline and Annual Repeat Rounds. AJR Am J Roetgenol 2016; 11:1-9.
  1. Hu M, Yip R, Yankelevitz DF, Henschke CI. CT Screening for lung cancer: Frequency of enlarged adrenal glands identified in baseline and annual repeat rounds. Eur Radiol 2016; 26: 4475-81.
  1. Flores RM, Nicastri D, Bauer T, Aye R, Andaz S, Kohman L, Sheppard B, Mayfield W, Thurer R, Korst R, Straznicka M, Grannis F, Pass H, Connery C, Yip R, Smith JP, Yankelevitz DF, Henschke CI and Altorki NK. Computed Tomography Screening for Lung Cancer Mediastinal Lymph Node Resection in Stage IA Nonsmall Cell Lung Cancer Manifesting as Subsolid and Solid Nodules. Ann Surg. 2017; 265:1025-1033.
  1. Schwartz R, Yip R, Olkin I, Sikavi D, Taioli E, Henschke CI for the I-ELCAP Investigators. Impact of Surgery for Stage 1A Non-small Cell Lung Cancer on Quality of Life. J Community Support Oncol 2016; 14:37-44.
  1. Yip R, Li K, Hu M, Jiranapatakul A, Henschke CI, Yankelevitz DF. Lung Cancer Deaths in the National Lung Screening Trial Attributed to Nonsolid Nodules. Radiology 2016; 281: 589-96.
  1. Henschke CI, Yankelevitz DF, Yip R, Archer V, Zahlmann G, Krishnan K, Helba B, Avila R. Tumor volume measurement error using computed tomography imaging in a phase II clinical trial in lung cancer. J Med Imag 2016; 3:035505.
  1. Yankelevitz D and Henschke C. Lung Cancer: low-dose CT screening – determining the right interval. Nat Rev Clin Oncol. 2016; 13:533-4.
  1. Schwartz RM, Yip R, Flores RM, Olkin I, Taioli E, Henschke C; I-ELCAP Investigators. The impact of resection method and patient factors on quality of life among stage IA non-small cell lung cancer surgical patients. J Surg Oncol 2017; 115:173-180.
  1. Yip R, Henschke CI, Xu DM, Li K, Jirapatnakul A, Yankelevitz DF. Lung Cancers Manifesting as Part-Solid Nodules in the National Lung Screening Trial. AJR Am J Roentgenol 2017; 208: 1011-1021.
  1. Yankelevitz DF, Cham MD, Hecht HS, Yip R, Shemesh S, Narula J, Henschke CI. The association of secondhand tobacco smoke and CT angiography-verified coronary atherosclerosis. JACC Cardiovasc Imaging 2017; 10: 652-659.
  2. Li K, Yip R, Yankelevitz DF, Henschke CI. Size and Growth Assessment of Pulmonary Nodules: Consequences of the Rounding. J Thorac Oncol 2017; 12:657-662.
  1. Barta JA, Henschke CI, Flores RM, Yip R, Yankelevitz DF, Powell CA. Lung Cancer Diagnosis by Fine Needle Aspiration is Associated with Reduction in Resection of Nonmalignant Lung Nodules. Ann Thorac Surg 2017; 103: 1795-1801.
  1. Pyenson B, Henschke CI, Yankelevitz DF. Editorial: Population health’s unanimity on lung cancer screening: far ahead of medical advice. Ann Transl Med 2017; 5: 355.
  1. Liang M, Yip R, Tang W, Xu Dongming, Reeves AP, Henschke CI, Yankelevitz DF. Variation in Screening CT- Detected Nodule Volumetry as a Function of Size. AJR Am J Roentgenol 2017; 209: 304-308.
  1. Chen X, Li K, Yip R, Perumalswami P, Branch AD, Lewis S, Del Bello D, Becker BJ, Yankelevitz DF, Henschke CI. Hepatic steatosis in participants in a program of low-dose CT screening for lung cancer. Eur Radiol 2017; 94: 174-179. PMID: 28712697.
  1. Wolf AS, Swanson SJ, Yip R, Liu B, Tarras ES, Yankelevitz DF, Henschke CI, Taioli E, Flores RM. The Impact of Margins on Outcomes after Wedge Resection for Stage 1 Non-Small Cell Lung Cancer. Ann Thor Surg 2017; 104:1171-1178.
  1. Dodson RF, Black B. Bruce JR, Poye LW, Henschke C, Loewen G. A clinical assessment and lung tissue burden from an individual who worked as a Libby vermiculite miner. Inhalation Toxicology. 2017; 29: 404-413.
  1. Salvatore M, Henschke C, Yip R, Kaur S, Li K, Padilla M, Yankelevitz D. Osteophyte induced lung fibrosis: prevalence and osteophyte qualities predicting disease. Clin Imag 2017; 44:1-4.
  1. Chung M, Tam K, Wallace C, Yip R, Yankelevitz DF, Henschke CI for the I-ELCAP Investigators. International Early Lung Cancer Action Program: Update on Lung Cancer Screening and The Management of CT Screening-detected Findings. AME Med J 2017; 2:129.
  1. Flores R, Taioli E, Yankelevitz DF, Becker BJ, Jirapatnakul A, Reeves A, Schwartz R, Yip R, Fevrier E, Tam K, Steiger B and Henschke CI. Initiative for Early Lung Cancer Research on Treatment: Development of Study Design and Pilot Implementation. J Thorac Oncol. 2018; 13:946-957.
  1. Henschke CI, Salvatore M, Cham M, Powell CA, DiFabrizio L, Flores R, Kaufman A, Eber C, Yip R, Yankelevitz DF and International Early Lung Cancer Action Program I. Baseline and annual repeat rounds of screening: implications for optimal regimens of screening. Eur Radiol. 2018; 28:1085-1094.
  1. Kong CY, Sigel K, Criss SD, Sheehan DF, Triplette M, Silverberg MJ, Henschke CI, Justice A, Braithwaite RS, Wisnivesky J and Crothers K. Benefits and harms of lung cancer screening in HIV-infected individuals with CD4+ cell count at least 500 cells/μl. 2018; 32:1333-1342.
  1. Liu Y, Yankelevitz DF, Kostakoglu L, Beasley MB, Htwe Y, Salvatore MM, Yip R and Henschke CI. Updating the role of FDG PET/CT for evaluation of lung cancer manifesting in nonsolid nodules. Clin Imaging. 2018; 52:157-162.
  1. Margolies LR, Salvatore M, Yip R, Tam K, Bertolini A, Henschke C and Yankelevitz D. The chest radiologist’s role in invasive breast cancer detection. Clinical Imaging. 2018; 50:13-19.
  1. Miller A, Szeinuk J, Noonan CW, Henschke CI, Pfau J, Black B, Yankelevitz DF, Liang M, Liu Y, Yip R, McNew T, Linker L and Flores R. Libby Amphibole Disease: Pulmonary Function and CT Abnormalities in Vermiculite Miners. J Occup Environ Med. 2018; 60:167-173.
  1. Salvatore M, Margolies L, Bertolini A, Singh A, Yankelevitz D and Henschke C. The need to be all inclusive: Chest CT scans should include imaged breast parenchyma. Clinical Imaging. 2018; 50:243-245.
  1. Schwartz RM, Gorbenko K, Kerath SM, Flores R, Ross S, Taylor TN, Taioli E and Henschke C. Thoracic surgeon and patient focus groups on decision-making in early-stage lung cancer surgery. Future Oncol. 2018; 14:151-163.
  1. Veronesi G, Zulueta JJ, Maisonneuve P and Henschke C. At last we can go ahead with low-dose CT screening for lung cancer in Europe. Lung Cancer. 2018; 123:176-177.
  1. Yip R, Li K, Liu L, Xu D, Tam K, Yankelevitz DF, Taioli E, Becker B and Henschke CI. Controversies on lung cancers manifesting as part-solid nodules. Eur Radiol. 2018; 28:747-759.
  1. Yip R, Ma T, Flores RM, Yankelevitz D and Henschke CI. Survival with Parenchymal and Pleural Invasion of Non-Small Cell Lung Cancers Less than 30 mm. J Thorac Oncol. 2019; 14:890-902.
  1. Yip R, Taioli E, Schwartz R, Li K, Becker BJ, Tam K, Htwe YM, Yankelevitz DF and Henschke CI. A Review of Quality of Life Measures used in Surgical Outcomes for Stage I Lung Cancers. Cancer Invest. 2018; 36:296-308.
  1. Adler S, Yankelevitz D, Henschke C, Siddique M. Quality assurance in CT screening for lung cancer. Women of Science 2017-2018. Yeshiva University, Stern College for Women; 97-102.
  1. Berlin E, Buckstein M, Yip R, Yankelevitz DF, Rosenzweig K and Henschke CI. Definitive Radiation for Stage I Lung Cancer in a Screened Population: Results from the I-ELCAP. Int J Radiat Oncol Biol Phys. 2019; 104:122-126.
  1. González J, Henschke CI, Yankelevitz DF, Seijo LM, Reeves AP, Yip R, Xie Y, Chung M, Sánchez-Salcedo P, Alcaide AB, Campo A, Bertó J, Del Mar Ocón M, Pueyo J, Bastarrika G, de-Torres JP and Zulueta JJ. Emphysema phenotypes and lung cancer risk. PLoS One. 2019;14: e0219187.
  2. Henschke CI, Yankelevitz DF, Reeves AP and Yip R. Evolution of Lung Cancer Screening Management. Oncology
    (Williston Park).     2019;33: 629380.
  1. Henschke CI, Yip R, Ma T, Aguayo SM, Zulueta J and Yankelevitz DF. CT screening for lung cancer: comparison of three baseline screening protocols. Eur Radiol. 2019; 29:5217-5226.
  1. Margolies LR, Yankelevitz DF and Henschke CI. Reply to “Mammographic Reporting of Breast Arterial Calcification”. AJR Am J Roentgenol. 2019;213: W146.
  1. Salvatore M, Singh A, Yip R, Fevrier E, Henschke CI, Yankelevitz D and Padilla M. Progression of probable UIP and UIP on HRCT. Clin Imaging. 2019; 58:140-144.
  1. Triphuridet N and Henschke C. Landscape on CT screening for lung cancer in Asia. Lung Cancer (Auckland, N.Z.). 2019; 10:107-124.
  1. Whittaker Brown S-A, Padilla M, Mhango G, Powell C, Salvatore M, Henschke C, Yankelevitz D, Sigel K, de-Torres JP and Wisnivesky J. Interstitial Lung Abnormalities and Lung Cancer Risk in the National Lung Screening Trial. 2019; 156:1195-1203.
  1. Yankelevitz DF, Chan C, Henschke CI. Overdiagnosis: “A Malformed Concept”. J Thorac Imaging. 2019; 34:151-153.
  1. Bertolini A, Capaccione K, Austin JHM, Blum A, Padilla M, B DS, Yankelevitz D, Henschke CI and Salvatore MM. Teleradiology: An opportunity to improve outcomes in pulmonary fibrosis. Clin Imaging. 2020; 60:263-264.
  1. Chen X, Ma T, Yip R, Perumalswami PV, Branch AD, Lewis S, Crane M, Yankelevitz DF and Henschke CI. Elevated prevalence of moderate-to-severe hepatic steatosis in World Trade Center General Responder Cohort in a program of CT lung screening. Clin Imaging. 2020; 60:237-243.
  1. Février E, Yip R, Becker BJ, Taioli E, Yankelevitz DF, Flores R, Henschke CI and Schwartz RM. Change in quality of life of stage IA lung cancer patients after sublobar resection and lobectomy. J Thorac Dis. 2020; 12:3488-3499.
  1. Henschke CI. Dual-energy computed tomography for pre-surgical identification of adenocarcinoma subtypes. Transl Lung Cancer Res. 2020; 9:432-433.
  1. Henschke CI, Yip R, Shaham D, Zulueta J, Aguayo SM, Reeves AP, Jirapatnakul AC, Avila R, Mogahanaki D, Yankelevitiz DF and for the I-ELCAP Investigators. The Regimen of Computed Tomography Screening for Lung Cancer. Lessons Learned Over 25 Years from the International Early Lung Cancer Action Program. J Thorac Imaging. 2021; 36: 6-23.
  1. Jirapatnakul A, Reeves AP, Lewis S, Chen X, Ma T, Yip R, Chin X, Liu S, Perumalswami PV, Yankelevitz DF, Crane M, Branch AD and Henschke CI. Automated measurement of liver attenuation to identify moderate-to-severe hepatic steatosis from chest CT scans. Eur J Radiol. 2020; 122:108723.
  1. Liu B, Dharmarajan K, Henschke CI and Taioli E. State-Level Variations in the Utilization of Lung Cancer Screening Among Medicare Fee-for-Service Beneficiaries: An Analysis of the 2015 to 2017 Physician and Other Supplier Data. 2020; 157:1012-1020.
  1. Liu B, Henschke CI, Flores RM and Taioli E. Serum cotinine verification of self-reported smoking status among adults eligible for lung cancer screening in the 1999-2018 National Health and Nutrition Examination Survey. Lung Cancer. 2020; 144:49-56.
  1. Margolies LR, Salvatore M, Tam K, Yip R, Bertolini A, Henschke CI and Yankelevitz DF. Breast mass assessment on chest CT: Axial, sagittal, coronal or maximal intensity projection? Clin Imaging. 2020; 63:60-64.
  1. Mulshine JL, Avila RS, Conley E, Devaraj A, Ambrose LF, Flanagan T, Henschke CI, Hirsch FR, Janz R, Kakinuma R, Lam S, McWilliams A, Van Ooijen PMA, Oudkerk M, Pastorino U, Reeves A, Rogalla P, Schmidt H, Sullivan DC, Wind HHJ, Wu N, Wynes M, Xueqian X, Yankelevitz DF and Field JK. The International Association for the Study of Lung Cancer Early Lung Imaging Confederation. JCO Clin Cancer Inform. 2020; 4:89-99.
  1. Salvatore M, Toussie D, Pavlishyn N, Yankelevitz D, O’Connor T, Henschke C, and Padilla M. The right upper lobe bronchus angle: A tool for differentiating fibrotic and non-fibrotic sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases: official journal of WASOG / World Association of Sarcoidosis and Other Granulomatous Disorders. 2020; 37:99-103.
  1. Steiger D, Han D, Yip R, Li K, Chen X, Liu L, Liu J, Ma T, Siddiqi F, Yankelevitz DF and Henschke CI. Increased main pulmonary artery diameter and main pulmonary artery to ascending aortic diameter ratio in smokers undergoing lung cancer screening. Clin Imaging. 2020; 63:16-23.
  1. Veronesi G, Baldwin DR, Henschke CI, Ghislandi S, Iavicoli S, Oudkerk M, De Koning HJ, Shemesh J, Field JK, Zulueta JJ, Horgan D, Fiestas Navarrete L, Valentino Infante M, Novellis P, Murray RL, Peled N, Rampinelli C, Rocco G, Rzyman W, Scagliotti GV, Tammemagi MC, Bertolaccini L, Triphuridet N, Yip R, Rossi A, Senan S, Ferrante G, Brain K, van der Aalst C, Bonomo L, Consonni D, Van Meerbeeck JP, Maisonneuve P, Novello S, Devaraj A, Saghir Z and Pelosi G. Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe. Cancers (Basel). 2020;12:0.
  1. Wang Y, Zhu Y, Yip R, Lee DS, Flores RM, Kaufman A, Henschke CI, Yankelevitz DF; I-ELCAP Investigators. Pre-surgical assessment of mediastinal lymph node metastases in Stage IA non-small-cell lung cancers. Clin Imaging. 2020; 68:61-67.
  1. Siddique M, Yip R, Henschke CI and Yankelevitz DF. PET standardized uptake values of primary lung cancer for comparison with tumor volume doubling times. Clin Imaging 2021; 73:146-150.
  1. Lewis JA, Spalluto LB, Henschke CI, Yankelevitz DF, Aguayo SM, Morales P, Avila R, Audet CM, Prusaczyk B, Lindsel CJ, Callaway-Lane C, Dittus RS, Vogus TJ, Massion PP, Limper HM, Kripalani S, Moghanaki D, Roumie CL. Protocol to Evaluate an Enterprise-Wide Initiative to Increase Access to Lung Cancer Screening in the Veterans Health Administration. Clin Imaging 2021; 73: 151-161.
  1. Henschke CI. Yankelevitz DF, Jirapatnakul A, Yip R, Reccoppa V, Benjamin C, Llamo T, Williams A, Liu S, Max D, and Aguayo S, Morales P, Igel BJ, Abbaszadegan H, Fredricks PA, Garcia DP, Permana PA, Fawcett J, Sultan S, Murphy LA. Implementation of low-dose CT screening in two different health care systems: Mount Sinai Healthcare System and Phoenix VA Health Care System. Transl Lung Cancer Res. 2021: 10: 1064-1082.
  1. Spalluto LB, Lewis JA, Stolldorf D, Yeh VM, Callaway-Lane C, Wiener RS, Slatore CG, Yankelevitz DF, Henschke CI, Vogus TJ, Massion PP, Moghanaki D, Roumie CL. Organizational Readiness for Lung Cancer Screening: A Cross-Sectional Evaluation at a Veterans Affairs Medical Center.J Am Coll Radiol. 2021; 18: 809-819.
  1. Zhu Y, Wang Y, Gioia W, Yip R, Jirapatnakul A, Chung M, Yankelevitiz D and Henschke C. Visual Scoring of Aortic Valve Calcifications on Low-Dose CT in Lung Cancer Screening. Eur Radiol. 2020 May; 30(5):2658-2668.
  1. Zhu Y, Yip R, Shemesh J, Jirapatnakul AC, Yankelevitz DF and Henschke CI. Combined aortic valve and coronary artery calcifications in lung cancer screening as predictors of death from cardiovascular disease. Eur Radiol. 2020; 30: 6847-6857.
  1. Zhu Y, Yip R, You N, Henschke CI, Yankelevitz DF. Management of Nodules Attached to the Costal Pleura at Low-dose CT Screening for Lung Cancer. Radiology 2020; 297:710-718.
  1. Zhang L, Yip R, Li M, Cai Q, Henschke CI, Yankelevitz DF, I-ELCAP Investigators. Lung cancer screening intervals based on cancer risk. Lung Cancer 2020; 149:113-119.
  1. Yankelevitz DF, Henschke CI. Overdiagnosis in lung cancer screening. Transl Lung Cancer Res. 2021; 10: 1136-1140.
  1. Yip R, Jirapatnakul A, Hu M, Chen X, Han D, Ma T, Zhu Y, Salvatore MM, Margolies LR, Yankelevitz DF, Henschke CI. Added benefits of early detection of other diseases on low-dose CT screening. Transl Lung Cancer Res. 2021; 10: 1141-1153.
  1. Li K, Liu X, Yip R, Yankelevitz DF, Henschke CI, Geng Y, Fang Y, Li W, Pan C, Chen X, Qin P, Zhong Y, Liu K, Li S. Early prediction of severity in coronavirus disease (COVID-19) using quantitative CT imaging. Clin Imaging. 2021; 78: 223-229. doi: 10.1016/j.clinimag.2021.02.003. PMID: 34058647.
  1. Fuhrman JD, Yip R, Jirapatnakul AC, Henschke CI, Yankelevitz DF, Giger ML. Cascade of U-Nets in the detection and classification of coronary artery calcium in thoracic low-dose CT. Medical Imaging 2020: Computer-Aided Diagnosis; 112140A (2020).
  1. Fuhrman JD, Kremer L, Zhu Y, Yip R, Li F, Lan L, Li H, Jirapatnakul A, Henschke CI, Yankelevitz DY, Giger ML. Radiomic texture analysis for the assessment of osteoporosis on low-dose thoracic CT scans. Medical Imaging 2021: Computer-Aided Diagnosis; 1159730 (2021).
  1. Jirapatnakul A, Yip R, Branch A, Lewis S, Crane M, Yankelevitz DF, Henschke CI. Dose-response relationship between World Trade Center dust exposure and hepatic steatosis. Am J Ind Med. 2021; 64: 837-844.
  1. Yip R, Jirapatnakul A, Li M, Yankelevitz DF, Henschke CI. Review of the future of lung cancer screening. Curr Chall Thorac Surg doi: 10.21037/ccts-20-125.
  1. Zhu Y, Yip R, You N, Cai Q, Henschke CI, Yankelevitz DF, I-ELCAP investigators. Characterization of Newly Detected Costal Pleura-attached Noncalcified Nodules at Annual Low-dose CT Screenings. 2021; 301(3): 724-731.
  1. Steiger D, F Siddiqi M, Yip R, Yankelevitz DF, Henschke CI, on behalf of the I-ELCAP investigators. The importance of low-dose CT screening to identify emphysema in asymptomatic participants with and without a prior diagnosis of COPD. Clin Imaging. 2021; 78:136-141. https://doi.org/10.1016/j.clinimag.2021.03.012 (associated editorial by Rizzo A and Mulshine J.) (ASCO Press 2021; 12:16: August 25, 2021) PMID: 33799061.
  1. Kerpel-Fronius F, Tammemägi M, Cavic M, Henschke CI, Jiang L, Kazerooni E, Lee C-T, Ventura L, Yang D, Lam S, Huber RM, for the members of the Diagnostics and Working Group, ED & Screening Committee. Screening for lung cancer in individuals who never smoked: an International Association for the Study of Lung Cancer Early Detection and Screening Committee Report. J Thorac Oncol. 2021; S1556-0864(21)02391-1.
  1. Zhu Y, Cai Q, Wang Y, You N, Yip R, Lee DS,Taioli E, Flores R, Henschke CI, Yankelevitz DF for the IELCART Investigators. Pre-surgical assessment of mediastinal lymph node metastases in patients having ≤30mm non-small-cell lung cancers. Lung Cancer. 2021; 161: 189-196.
  1. Cham M, Henschke CI, Yankelevitz DF. The radiologist’s role in pathologic diagnosis of small lung nodules: radiographic methods of tissue acquisition. Curr Chall Thorac Surg 2021.
  1. Li M, Cai Q, Ma JW, Zhang L, Henschke CI. The 100 most cited articles on lung cancer screening; a bibliometric analysis. Ann Transl Med. 2021;9(9):787.
  1. Yankelevitz DF, Flores RM, Taioli E, Henschke CI. Is the Evidence for Thoracic Surgery of Early Stage Lung Cancer Adequate? Ann Surg 2021; 274:e635-e637.
  1. Zhu Y, Triphuridet N, Yip R, Becker BJ, Wang Y, Yankelevitz DF, Henschke CI. Opportunistic CT screening of osteoporosis on thoracic and lumbar spine: a meta-analysis. Clin Imaging 2021; 80: 382-390.
  1. Henschke CI, Huber RM, Jiang L, Yang D, Cavic M, Schmidt H, Kazerooni E, Zulueta J, dos Santos RS, Ventura L, for the members of the Diagnostics and Working Group, ED & Screening Committee. Clinical Management of Abnormal LDCT Findings on Low-Dose Computed Tomography Examinations for Lung Cancer Screening.  submitted to J Thorac Oncol 2021.
  1. Huber RM, Cavic M, Kerpel-Fronius F, Viola L, Field J, Jiang L, Kazerooni EA, Koegelenberg CFN, Mohan A, dos Sales RS, Ventura L, Wynes M, Yang D, Zulueta J, Lee CT, Tammemagi MC, Henschke CI, Lam S, for the members of the Diagnostics and Working Group, ED & Screening Committee. Lung cancer screening considerations during respiratory infection outbreaks, epidemics or pandemics: an IASLC Early Detection and Screening Committee Report. J Thorac Oncol. 2022; 17(2):228-238.
  1. Schwartz RM, Yip R, You N, Gillezeau C, Song K, Yankelevitz DF, Taioli E, Henschke CI, Flores RM for the IELCART Investigators. Early stage lung cancer patients perceptions’ of pre-surgical discussions. MDM Policy Pract. 2022;7(1):23814683221085570.
  1. Nicastri D, Chan H, You N, Yip R, Ray K, Taioli E, Yankelevitz DF, Henschke CI, Flores RM. Effects of smoking, obesity, and pulmonary function on home oxygen use after curative lung cancer surgery. Ann Am Thorac Soc. 2022; 19(3):442-450.
  1. Spalluto LB, Lewis JA, Samuels LR, Callaway-Lane C, Matheny ME, Denton J, Robles JA, Dittus RS, Yankelevitz DY, Henschke CI, Massion PP, Moghanaki D, Roumie CL.  Association of Rurality with Annual Repeat Lung Cancer Screening in the Veterans Health Administration. J Am Coll Radiol. 2022; 19(1 Pt B):131-138.
  1. Cai Q, Triphurdit N, Zhu Y, Nan Y, Yip R, Yankelevitz DF, Henschke CI. Bronchiectasis in Low-Dose CT Screening for Lung Cancer. Radiology 2022; 304(2):437-447.
  1. Song KJ, Yip R, Chung M, Cai Q, Zhu Y, Singh A, Lewis EE, Yankelevitz DF, Taioli E, Henschke CI, Flores R; IELCART and I-ELCAP Investigators. New or enlarged hiatal hernias after thoracic surgery for early lung cancer. JTCVS Open. 2022; 10: 415-423.
  1. Mack PC, Gomez JE, Rodilla AM, Carreno J, Hsu DY, Rolfo C, Meshulam N, Moore A, Broady R, King JC, Treatman J, Lee S, Raskin A, Srivastava K, Gleason CR, PARIS/PSP study grou, Tcheou J, Bielak D, Acharya R, Gerber DE, Rohs N, Henschke CI, Yankelevitz DF, Simon V, Minna JD, Bunn PA, Garcia-Sastre A, Krammer F. Shur Y, Hirsch FR. Longitudinal COVID-19 vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer. Cancer Cell. 2022;40(6):575-577.
  1. Wolf A, Laskey D, Yip R, Beasley MB,Yankelevitz DF, Henschke CI, for the IELCART Investigators. Measuring the Margin Distance in Pulmonary Wedge Resection. J Surg Oncol.
  1. Rolfo C, Mesulami N, Russo A, Krammer F, Garcia-Sastre A, Mack P, Gomez J, Bhardwaj N, Benyounces A, Sirera R, Moore A, Rohs N, Henschke C, Yankelevitz D, King J, Shyr Y, Bunn P, Minna J, Hirsch F. Lung Cancer and SARS-CoV-2 infection: Identifying important knowledge gaps for investigation. J Thorac Oncol. 2022; 17(2):214-227.
  1. Adler S, Yip R, Chan H, Cai Q, Zhu Y, Triphuridet N, Kaufman A, Taioli E, Flores RM, Henschke CI, Yankelevitz DF for the IELCART Investigators. Comparison of Lung Cancer Aggressiveness in Patients Who Never Smoked Compared to Those Who Smoked. Lung Cancer. 2022;171:90-96.
  1. Fuhrman JD, Zhu Y, Yip R, Feng L, Jirapatnakul A, Henschke CI, Yankelevitz DY, Giger ML. Multiple instance learning for automatic emphysema evaluation on low-dose CT lung cancer screening scans. SPIE PC12033, Medical Imaging 2022: Computer-Aided Diagnosis, PC1203305 (4 April 2022).
  1. Cai Q, Triphuridet N, Zhu Y, You N, Yip R, Yankelevitz DF, Henschke CI. Risk of exacerbations in Participants with Bronchiectasis in a Program of low-dose CT Screening. Radiology 2022; 304:437–447.
  1. Lung Cancer Roundtable Investigators (Fathi JT, Greenberg GM, Kazerooni E, Kim J, Mulshine JL, Pyenson BS, Shockney LD, Wiener RS, White CS. The American Cancer Society National Lung Cancer Roundtable Strategic Plan: Implementation of High Quality Lung Cancer Screening. Submitted to Cancer (CNCR-21-2119).  In press.
  1. Mulshine JL, Aldige CR, Ambrose LF, Armato SGII, Avila RS, Cham M, Estepar RSJ, Fain SB, Gazouian L, Gierada D, Hatt C, Henschke CI, Hoyos J, Lynch DA, McGlothin AK, Oudkerk M, Pasquinellli M, Pinsky P. Pyenson B, Rizzo AA, Ross SM, Schmitz KH, Silva M,Okwuosa T, Washko G, Wisnivesky J, Yankelevitz DF, Zulueta JJ. Emphysema detection in the course of Lung Cancer Screening: Optimizing a Rare Opportunity to Impact Population Health. Ann Am by Thorac Soc: 2023; 20(4):499-503.
  1. Yankelevitz DF, Yip R, Henschke CI. Impact of Duration of Diagnostic Workup on Prognosis for Early Lung Cancer. J Thor Oncol. 2023; 18(3): 527-537.
  1. Strayer TE, Spalluto LB, Burns A, Lindsell CJ, Henschke CI, Yankelevitz DF, Moghanaki D, Dittus RS, Vogus TJ, Audet C, Kripalani S, Roumie CL, Lewis Using the Framework for Reporting Adaptations and Modifications-Expanded (FRAME) to study adaptations in lung cancer screening delivery in the Veterans Health Administration: A cohort study. Implement Sci Commun. 2023 12;4(1):5.

© 2024 The International Early Lung Cancer Action Program
All rights reserved. Privacy Policy.